Wnt pathway activator 2

CAS No. 1360540-82-4

Wnt pathway activator 2( —— )

Catalog No. M33172 CAS No. 1360540-82-4

Wnt pathway activator 2, with an IC50 of 13 nM, is a potent Wnt activator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 107 In Stock
5MG 97 In Stock
10MG 155 In Stock
25MG 330 In Stock
50MG 523 In Stock
100MG 754 In Stock
200MG 1014 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Wnt pathway activator 2
  • Note
    Research use only, not for human use.
  • Brief Description
    Wnt pathway activator 2, with an IC50 of 13 nM, is a potent Wnt activator.
  • Description
    Wnt pathway activator 2 is a potent Wnt activator extracted from patent WO2012024404A1, compound 2, has an EC50s of 13 nM.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Wnt/beta/catenin
  • Recptor
    Wnt/beta-catenin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1360540-82-4
  • Formula Weight
    297.31
  • Molecular Formula
    C17H15NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (336.35 mM; Ultrasonic )
  • SMILES
    O=C(CCC(=O)c1ccccn1)c1ccc2OCCOc2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Charlene F. Barroga, et al. Diketones and hydroxyketones as catenin signaling pathway activators. WO2012024404A1.
molnova catalog
related products
  • Roquinimex

    Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and macrophage cytotoxicity; inhibits angiogenesis and reduces the secretion of TNF alpha.

  • NRX-252114 B

    NRX-252114 (NRX252114) induces degradation of mutant β-catenin NRX-252114 is a potent enhancer of the interaction of β-catenin with the homologous E3 ligase SCFβ-TrCP, and is able to enhance the binding of pSer33/S37A β-catenin to β-TrCP with an EC50 of 6.5 nM and a Kd of 0.4 nM. Kd is 0.4 nM.

  • Nesuparib

    Nesuparib (JPI-547/OCN-201) is a potent PARP inhibitor with inhibitory effects on PARP and TNKS1.